BCL2 and cancer: For instance, an anti-apoptotic factor Bcl-2 is overexpressed in the tumors of 35–50% of cancer patients [12], but heavy-ion irradiation can overcome tumor radioresistance caused by such Bcl-2 overexpression [13], [14].